SG3 Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,000
Closed -$59.9K 1406
2021
Q1
$51K Buy
+2,000
New +$50.1K ﹤0.01% 1091

Other funds holding RNLX

SG3 Management's RNLX Position: Q2 2021 in Review

SG3 Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q2 2021, closing a stake of 2,000 shares — an estimated $59.9K sold.

SG3 Management first reported a position in RNLX in Q1 2021 and held it in 1 quarter. The position peaked at $51K in Q1 2021. 41 funds tracked by Wall St. Rank hold RNLX as of Q2 2021.

  • SG3 Management reported no remaining Renalytix plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • SG3 Management sold 2,000 Renalytix plc American Depositary Shares shares in Q2 2021, an estimated $59.9K.
  • SG3 Management first reported a position in Renalytix plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • SG3 Management's Renalytix plc American Depositary Shares position peaked at $51K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q2 2021.

Based on SG3 Management's 13F filing for Q2 2021, filed 16 Aug 2021.